Skip to content
OpenSampling

2026 · Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · open access

Evaluation of hematocrit-adjusted conversion strategies for mycophenolic acid and tacrolimus monitoring using volumetric absorptive microsampling in lung and renal transplant recipients

Juan et al.

The finding, in our words

In lung and renal transplant recipients, VAMS sampling with LC-MS/MS quantification of mycophenolic acid and tacrolimus showed good linearity and accuracy, and with a haematocrit-adjusted conversion formula achieved clinical agreement in most samples; tacrolimus did not require haematocrit correction. The approach is virtually painless and enables richer sampling for more accurate drug exposure estimates, supporting decentralised therapeutic drug monitoring.

A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.

Labels

  1. 2025

    A validated LC-MS/MS method for everolimus using Mitra and Capitainer devices found excellent agreement between capillary microsamples and venous whole blood in 33 adult transplant recipients. The results showed high accuracy and negligible haematocrit effects, supporting the use of microsampling for decentralised therapeutic drug monitoring.

    Therapeutic Drug Monitoring of Everolimus Using Volumetric Absorptive Microsampling and Quantitative Dried Blood Spot Methods with LC-MS/MS in Adult Solid Organ Transplant Recipients: An Analytical and Clinical Comparative StudyKocur et al., Molecules · source ↗

    • vams
    • venous-agreement
    • neoteryx-mitra
    • blood
    • qdbs
    • tdm
    • haematocrit
    • dried
    • capillary
    • immunosuppressants
    • validation
  2. 2024

    The study validated a VAMS-based LC-MS/MS method for measuring sirolimus levels, showing it was clinically equivalent to the standard whole blood method and suitable for therapeutic drug monitoring in paediatric transplant patients, supporting the use of decentralised microsampling for this purpose.

    Personalization of pharmacotherapy with sirolimus based on volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients-from LC-MS/MS method validation to clinical applicationKocur et al., Pharmacological reports : PR · source ↗

    • vams
    • venous-agreement
    • neoteryx-mitra
    • blood
    • tdm
    • haematocrit
    • dried
    • capillary
    • pediatric
    • immunosuppressants
    • validation
  3. 2023

    A study of 50 paediatric renal transplant recipients found that a validated VAMS LC-MS/MS method for tacrolimus showed high correlation with the reference method over 0.5–60 ng/mL, with minimal haematocrit effect.

    Therapeutic Drug Monitoring of Tacrolimus Based on VAMS in Renal Transplant Pediatric Recipients — LC-MS/MS Method, Hematocrit Effect, and Clinical ApplicationKocur et al., Pharmaceutics · source ↗

    • vams
    • venous-agreement
    • neoteryx-mitra
    • blood
    • tdm
    • haematocrit
    • dried
    • capillary
    • pediatric
    • immunosuppressants
    • validation
  4. 2022

    Clinical validation for tacrolimus and mycophenolic acid monitoring showed that while volumetric absorptive microsampling met analytical criteria after concentration correction, conventional dried blood spots achieved superior adherence to strict clinical criteria, sample quality, and cost efficiency without significant haematocrit bias.

    Comparison of conventional dried blood spots and volumetric absorptive microsampling for tacrolimus and mycophenolic acid determinationPaniagua-González et al., Journal of pharmaceutical and biomedical analysis (paywalled) · source ↗

    • blood
    • dried
    • capillary
    • vams
    • dbs
    • neoteryx-mitra
    • self-collection
    • validation
    • venous-agreement
    • tdm
    • immunosuppressants
    • economics
    • haematocrit
  5. 2026

    The study validated an LC-MS/MS method for eight antiepileptic drugs and two metabolites in dried blood spot and VAMS formats, with satisfactory analytical performance and stability, and was the first to include the oxcarbazepine metabolite DHCB. In 80 paired patient samples, microsampling concentrations showed promising correlation with plasma, supporting decentralised therapeutic drug monitoring of antiepileptic treatment.

    Development and application of an LC-MS/MS method for 8 antiepileptic drugs and 2 metabolites using microsampling techniques (DBS and VAMS)Cobo-Golpe et al., Journal of analytical toxicology · source ↗

    • blood
    • dried
    • vams
    • dbs
    • neoteryx-mitra
    • validation
    • venous-agreement
    • tdm
    • haematocrit